Option Care Health, Inc. (OPCH)
USD 32.95
(2.42%)
USD 32.95
(2.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 666.62 Million USD | -3.07% |
| 2022 | 626.68 Million USD | 6.44% |
| 2021 | 588.76 Million USD | 3.02% |
| 2020 | 571.5 Million USD | 11.34% |
| 2019 | 513.31 Million USD | 127.46% |
| 2018 | 225.67 Million USD | -2.25% |
| 2017 | 230.86 Million USD | -0.27% |
| 2016 | 231.49 Million USD | 0.1% |
| 2015 | 231.26 Million USD | -6.13% |
| 2014 | 246.36 Million USD | 2.78% |
| 2013 | 239.7 Million USD | 27.2% |
| 2012 | 188.44 Million USD | -29.13% |
| 2011 | 265.91 Million USD | 13.63% |
| 2010 | 234.01 Million USD | 64.38% |
| 2009 | 142.35 Million USD | -36.92% |
| 2008 | 225.68 Million USD | 76.09% |
| 2007 | 128.16 Million USD | -5.61% |
| 2006 | 135.77 Million USD | -6.66% |
| 2005 | 145.47 Million USD | 160.41% |
| 2004 | 55.86 Million USD | 6.41% |
| 2003 | 52.49 Million USD | 13.02% |
| 2002 | 46.45 Million USD | 21.56% |
| 2001 | 38.21 Million USD | -1.47% |
| 2000 | 38.78 Million USD | 24.2% |
| 1999 | 31.22 Million USD | 25.92% |
| 1998 | 24.8 Million USD | 22.77% |
| 1997 | 20.2 Million USD | -48.21% |
| 1996 | 39 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 153.78 Million USD | -9.26% |
| 2024 Q1 | 169.47 Million USD | 14.67% |
| 2024 Q3 | 171.65 Million USD | 11.62% |
| 2023 FY | 607.42 Million USD | -3.07% |
| 2023 Q1 | 162.38 Million USD | -0.31% |
| 2023 Q2 | 168.46 Million USD | 3.75% |
| 2023 Q3 | 173.21 Million USD | 2.82% |
| 2023 Q4 | 147.78 Million USD | -14.68% |
| 2022 Q3 | 157.28 Million USD | -0.34% |
| 2022 Q4 | 162.88 Million USD | 3.56% |
| 2022 Q1 | 148.69 Million USD | -1.81% |
| 2022 Q2 | 157.82 Million USD | 6.14% |
| 2022 FY | 626.68 Million USD | 6.44% |
| 2021 Q3 | 150.08 Million USD | -0.52% |
| 2021 Q4 | 151.42 Million USD | 0.89% |
| 2021 Q1 | 136.37 Million USD | -2.18% |
| 2021 FY | 588.76 Million USD | 3.02% |
| 2021 Q2 | 150.87 Million USD | 10.63% |
| 2020 Q3 | 139.59 Million USD | -2.46% |
| 2020 Q1 | 149.38 Million USD | -7.6% |
| 2020 Q2 | 143.11 Million USD | -4.2% |
| 2020 Q4 | 139.41 Million USD | -0.13% |
| 2020 FY | 571.5 Million USD | 11.34% |
| 2019 Q1 | 56.75 Million USD | 0.26% |
| 2019 Q4 | 161.66 Million USD | 8.14% |
| 2019 Q3 | 149.49 Million USD | 172.36% |
| 2019 Q2 | 54.88 Million USD | -3.28% |
| 2019 FY | 513.31 Million USD | 127.46% |
| 2018 Q4 | 56.6 Million USD | 0.26% |
| 2018 Q2 | 56.15 Million USD | -0.52% |
| 2018 Q1 | 56.45 Million USD | 0.66% |
| 2018 FY | 225.67 Million USD | -2.25% |
| 2018 Q3 | 56.46 Million USD | 0.54% |
| 2017 FY | 230.86 Million USD | -0.27% |
| 2017 Q2 | 59.3 Million USD | -2.51% |
| 2017 Q3 | 54.66 Million USD | -7.82% |
| 2017 Q4 | 56.08 Million USD | 2.6% |
| 2017 Q1 | 60.82 Million USD | -6.59% |
| 2016 FY | 231.49 Million USD | 0.1% |
| 2016 Q3 | 56.84 Million USD | 4.71% |
| 2016 Q2 | 54.28 Million USD | -1.74% |
| 2016 Q1 | 55.24 Million USD | 0.9% |
| 2016 Q4 | 65.11 Million USD | 14.56% |
| 2015 Q2 | 61.85 Million USD | 4.38% |
| 2015 Q3 | 54.88 Million USD | -11.27% |
| 2015 Q4 | 54.75 Million USD | -0.24% |
| 2015 FY | 231.26 Million USD | -6.13% |
| 2015 Q1 | 59.26 Million USD | -10.61% |
| 2014 Q4 | 66.29 Million USD | 9.9% |
| 2014 Q2 | 58.86 Million USD | -3.64% |
| 2014 FY | 246.36 Million USD | 2.78% |
| 2014 Q1 | 61.08 Million USD | -9.81% |
| 2014 Q3 | 60.32 Million USD | 2.48% |
| 2013 Q3 | 59 Million USD | 2.3% |
| 2013 Q4 | 67.73 Million USD | 14.79% |
| 2013 FY | 239.7 Million USD | 27.2% |
| 2013 Q1 | 54.87 Million USD | 9.31% |
| 2013 Q2 | 57.68 Million USD | 5.12% |
| 2012 Q2 | 49.34 Million USD | 0.69% |
| 2012 Q4 | 50.2 Million USD | -7.35% |
| 2012 Q1 | 49 Million USD | -26.74% |
| 2012 FY | 188.44 Million USD | -29.13% |
| 2012 Q3 | 54.18 Million USD | 9.81% |
| 2011 Q2 | 63 Million USD | -3.86% |
| 2011 Q3 | 65.68 Million USD | 4.25% |
| 2011 Q1 | 65.53 Million USD | -9.36% |
| 2011 Q4 | 66.89 Million USD | 1.84% |
| 2011 FY | 265.91 Million USD | 13.63% |
| 2010 Q2 | 58.94 Million USD | 46.71% |
| 2010 FY | 234.01 Million USD | 64.38% |
| 2010 Q4 | 72.3 Million USD | 15.52% |
| 2010 Q1 | 40.18 Million USD | -5.71% |
| 2010 Q3 | 62.58 Million USD | 6.17% |
| 2009 Q3 | 34.83 Million USD | 4.91% |
| 2009 FY | 142.35 Million USD | -36.92% |
| 2009 Q4 | 42.61 Million USD | 22.32% |
| 2009 Q2 | 33.2 Million USD | 4.72% |
| 2009 Q1 | 31.7 Million USD | -75.2% |
| 2008 FY | 225.68 Million USD | 76.09% |
| 2008 Q4 | 127.87 Million USD | 284.32% |
| 2008 Q1 | 32.18 Million USD | 0.56% |
| 2008 Q2 | 32.35 Million USD | 0.53% |
| 2008 Q3 | 33.27 Million USD | 2.82% |
| 2007 Q1 | 32.81 Million USD | -1.12% |
| 2007 FY | 128.16 Million USD | -5.61% |
| 2007 Q4 | 32 Million USD | -1.6% |
| 2007 Q3 | 32.52 Million USD | 5.55% |
| 2007 Q2 | 30.81 Million USD | -6.08% |
| 2006 Q1 | 31.8 Million USD | -47.91% |
| 2006 Q2 | 37.09 Million USD | 16.62% |
| 2006 Q3 | 33.67 Million USD | -9.22% |
| 2006 Q4 | 33.18 Million USD | -1.46% |
| 2006 FY | 135.77 Million USD | -6.66% |
| 2005 FY | 145.47 Million USD | 160.41% |
| 2005 Q1 | 17.56 Million USD | 11.91% |
| 2005 Q2 | 36.17 Million USD | 105.99% |
| 2005 Q3 | 30.12 Million USD | -16.72% |
| 2005 Q4 | 61.06 Million USD | 102.68% |
| 2004 Q2 | 13.37 Million USD | 1.83% |
| 2004 Q3 | 13.66 Million USD | 2.13% |
| 2004 Q4 | 15.69 Million USD | 14.88% |
| 2004 Q1 | 13.13 Million USD | -2.89% |
| 2004 FY | 55.86 Million USD | 6.41% |
| 2003 Q1 | 12.67 Million USD | -6.41% |
| 2003 Q4 | 13.52 Million USD | 3.28% |
| 2003 Q3 | 13.09 Million USD | -0.79% |
| 2003 Q2 | 13.2 Million USD | 4.15% |
| 2003 FY | 52.49 Million USD | 13.02% |
| 2002 Q3 | 12.12 Million USD | 5.99% |
| 2002 Q4 | 13.54 Million USD | 11.65% |
| 2002 Q2 | 11.44 Million USD | 22.61% |
| 2002 Q1 | 9.33 Million USD | -18.54% |
| 2002 FY | 46.45 Million USD | 21.56% |
| 2001 Q3 | 8.88 Million USD | -10.55% |
| 2001 Q4 | 11.45 Million USD | 29.03% |
| 2001 Q1 | 7.94 Million USD | -42.69% |
| 2001 Q2 | 9.92 Million USD | 25.02% |
| 2001 FY | 38.21 Million USD | -1.47% |
| 2000 Q2 | 8.33 Million USD | 15.63% |
| 2000 Q4 | 13.85 Million USD | 47.8% |
| 2000 Q3 | 9.37 Million USD | 12.46% |
| 2000 FY | 38.78 Million USD | 24.2% |
| 2000 Q1 | 7.21 Million USD | -9.06% |
| 1999 Q2 | 7.7 Million USD | -4.94% |
| 1999 Q4 | 7.92 Million USD | 4.33% |
| 1999 Q3 | 7.6 Million USD | -1.3% |
| 1999 Q1 | 8.1 Million USD | -2.41% |
| 1999 FY | 31.22 Million USD | 25.92% |
| 1998 Q4 | 8.3 Million USD | 25.76% |
| 1998 FY | 24.8 Million USD | 22.77% |
| 1998 Q1 | 4.9 Million USD | -22.22% |
| 1998 Q2 | 5.1 Million USD | 4.08% |
| 1998 Q3 | 6.6 Million USD | 29.41% |
| 1997 Q4 | 6.3 Million USD | 14.55% |
| 1997 Q3 | 5.5 Million USD | 27.91% |
| 1997 Q2 | 4.3 Million USD | 4.88% |
| 1997 Q1 | 4.1 Million USD | -2.38% |
| 1997 FY | 20.2 Million USD | -48.21% |
| 1996 FY | 39 Million USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q4 | 4.2 Million USD | 31.25% |
| 1996 Q3 | 3.2 Million USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -278.738% |
| Addus HomeCare Corporation | 248.92 Million USD | -167.808% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -463.402% |
| Amedisys, Inc. | 834.47 Million USD | 20.114% |
| Astrana Health, Inc. | 112.59 Million USD | -492.048% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | -13.496% |
| IMAC Holdings, Inc. | 5.02 Million USD | -13160.618% |
| biote Corp. | 98.82 Million USD | -574.547% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -1793.538% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | -97.404% |
| COMPASS Pathways plc | 136.91 Million USD | -386.878% |
| DocGo Inc. | 180.32 Million USD | -269.676% |
| The Ensign Group, Inc. | 335.39 Million USD | -98.761% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -252.542% |
| InnovAge Holding Corp. | 558.25 Million USD | -19.413% |
| The Joint Corp. | 109.22 Million USD | -510.337% |
| LifeStance Health Group, Inc. | 491.23 Million USD | -35.706% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -3554.334% |
| ModivCare Inc. | 586.89 Million USD | -13.585% |
| NewGenIvf Group Limited | 1.63 Million USD | -40559.379% |
| P3 Health Partners Inc. | 199.56 Million USD | -234.041% |
| P3 Health Partners Inc. | 199.56 Million USD | -234.041% |
| The Pennant Group, Inc. | 88.99 Million USD | -649.062% |
| Surgery Partners, Inc. | 319.5 Million USD | -108.647% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -15404.783% |
| Talkspace, Inc. | 97.58 Million USD | -583.097% |
| Talkspace, Inc. | 97.58 Million USD | -583.097% |
| The Oncology Institute, Inc. | 136.59 Million USD | -388.047% |
| The Oncology Institute, Inc. | 136.59 Million USD | -388.047% |